Strides, Eli Lily tie up to tap emerging markets
Agila Specialties to make, Eli Lilly to market branded generic cancer meds
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Venus gets DCGI approval for phase III trial of cancer detection NCE
Venus is planning to launch this NCE by last quarter of 2013 in India
Piramal’s subsidiary, DRG acquires Abacus International
Acquisition adds significant global market access capabilities to DRG
The grim future
Rephrasing a common proverb, a lean compromise is better than a fat disguise. However, people of India do not seem to have taken…
DCGI to be competent national authority to certify API exports to EU
Draft guidelines for certification as per Falsified Medicines Directive, to be finalised by Jan 2013
Piramal Enterprises Healthcare in alliance with Fujifilm Diosynth Biotechnologies
Will offer the seamless contract development and manufacture of antibody drug conjugates